Development and Bioavailability Assessment of an Estriol-Containing Vaginal Hydrogel
2024

New Vaginal Gel for Menopause Symptoms

publication 10 minutes Evidence: moderate

Author Information

Author(s): Takacs Peter, Kozma Barbara, Rátonyi Dávid, Kozma Bence, Attila Kiss-Szikszai, Fenyvesi Ferenc, Sipos Attila G.

Primary Institution: University of Debrecen

Hypothesis

The study hypothesized that estriol would be efficiently released from the zinc-containing gel and effectively permeate the vaginal epithelium.

Conclusion

The novel vaginal gel formulation combining hydroxyethyl cellulose and hydroxypropyl-beta-cyclodextrin with estriol shows promise as a biocompatible and effective treatment for genitourinary syndrome of menopause.

Supporting Evidence

  • The gel showed increased cell viability and no obvious cytotoxicity in biocompatibility tests.
  • Estriol was effectively released from the gel and permeated the vaginal epithelium.
  • The hydrogel formulation provided superior comfort compared to traditional creams.

Takeaway

Researchers created a new gel to help women with menopause symptoms, and it works well without hurting cells.

Methodology

The study evaluated the gel's estriol release profile using a Franz diffusion cell system and tested its permeability on reconstructed human vaginal epithelium.

Limitations

The study had a short testing period of 72 hours and did not include in vivo testing.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.3390/gels10120823

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication